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Objective: Although a transjugular intrahepatic portosystemic shunt (TIPS) is commonly placed to manage isolated gastric
varices, balloon-occluded retrograde transvenous obliteration (BRTO) has also been used. We compare the long-term
outcomes from these procedures based on our institutional experience.
Materials and Methods: We conducted a retrospective review of patients with isolated gastric varices who underwent either
TIPS with a covered stent or BRTO between January 2000 and July 2013. We identified 52 consecutive patients, 27 who had
received TIPS with a covered stent and 25 who had received BRTO. We compared procedural complications, re-bleeding
rates, and clinical outcomes between the two groups.
Results: There were no significant differences in procedural complications between patients who underwent TIPS (7%) and
those who underwent BRTO (12%) (p = 0.57). There were also no statistically significant differences in re-bleeding rates
from gastric varices between the two groups (TIPS, 7% [2/27]; BRTO, 8% [2/25]; p = 0.94) or in developing new ascites
following either procedure (TIPS, 4%; BRTO, 4%; p = 0.96); significantly more patients who underwent TIPS developed
hepatic encephalopathy (22%) than did those who underwent BRTO (0%, p = 0.01). There was no statistically significant
difference in mean survival between the two groups (TIPS, 30 months; BRTO, 24 months; p = 0.16); median survival for the
patients who received TIPS was 16.6 months, and for those who underwent BRTO, it was 26.6 months.
Conclusion: BRTO is an effective method of treating isolated gastric varices with similar outcomes and complication rates
to those of TIPS with a covered stent but with a lower rate of hepatic encephalopathy.
Keywords: Gastric varices; Portal hypertension; Transjugular intrahepatic portosystemic shunt; Balloon-occluded retrograde
transvenous obliteration
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INTRODUCTION
Variceal bleeding from either esophageal or gastric
varices is a serious complication in patients with portal
hypertension. Although they are less prevalent and
less prone to bleeding than esophageal varices, gastric
varices are notoriously difficult to treat, often requiring
more transfusions; they are also associated with higher
mortality, up to 55% (1). Currently, treatment options
include medical, surgical, endoscopic, and endovascular
approaches, with endoscopic variceal sclerotherapy the
first line of treatment. However, due to the large size and
location of isolated gastric varices, long-term success in
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managing them endoscopically is limited (2-3). Transjugular
intrahepatic portosystemic shunt (TIPS) is also widely used
in managing gastric varices, but high-level evidence of its
benefits is lacking, and diverting portal blood flow can
further compromise liver function and aggravate hepatic
encephalopathy (4-6).
A number of studies have demonstrated balloon-occluded
retrograde transvenous obliteration (BRTO) as an effective
treatment method for isolated gastric varices, which are
often associated with spontaneous gastrorenal shunts (7).
By occluding portosystemic shunts, BRTO is thought to
improve liver function by increasing portal venous blood
flow; however, the increased portal pressure may increase
the risk of esophageal variceal bleeding, worsening ascites
and portal hypertensive gastropathy (8).
To date, only three studies directly compare the efficacy
and outcomes of TIPS and BRTO (9-11), and only one study
has evaluated the efficacy and outcomes of treating gastric
varices using TIPS with a covered stent. TIPS created with
bare metal stents are known to have lower patency rates
compared with covered stents and likely account for the
higher re-bleeding rates from TIPS procedures that were
found in previous studies (9, 10, 12-14).
Therefore, we here present a retrospective study
comparing the long-term outcomes of TIPS with covered
stents and BRTO in managing isolated gastric varices at our
institution.

MATERIALS AND METHODS
Patients
The Institutional Review Board approved this retrospective
study, and informed consent was waived. We performed a
retrospective cohort comparison of 52 consecutive patients
from our institution with bleeding gastric varices who were
treated with either TIPS using a covered stent or with BRTO.
Specifically, isolated gastric varices (Type 1 and 2) were
treated based on the Sarin classification (15). We searched
the Radiology Information Systems database for patients
who had undergone either TIPS or BRTO during the period
of January 2000 through July 2013. Before 2009, TIPS was
performed to manage isolated gastric varices. Since we
began using BRTO in 2009, the choice of TIPS vs. BRTO has
been based on the operator’s preference.
We reviewed electronic medical records for patient
demographics, pre-procedural clinical data, intra-procedural
information, and post-procedural data including immediate
346

and delayed complications and clinical, endoscopic and
imaging follow-up.
During the period of January 2000 through July 2013,
a total of 253 patients received TIPS for bleeding from
gastric, esophageal and/or rectal varices, of whom 27
patients with isolated gastric varices were treated with TIPS
using covered stents. Of these 27 patients, 26 had active
bleeding or recent history of gastric variceal bleeding, and
one had been treated with TIPS preoperatively prior to
rectal surgery. Supplemental embolization of gastric varices
with multiple coils had been performed in 10 of 27 patients
(37%) when there was persistent filling of gastric varices
after TIPS placement.
Beginning in November 2009 and through July 2013, 25
patients with isolated gastric varices underwent BRTO. Of
these 25 patients, 20 had active bleeding or recent history
of gastric variceal bleeding, and five had been treated for
prophylaxis. Sixteen of the 25 patients (57%) had had
supplemental collateral veins treated with procedures such
as inferior phrenic vein embolization.
The baseline characteristics of both groups of patients
are summarized in Table 1. There was no difference in
age between the TIPS and BRTO patients in regards to
age; the average age of the TIPS patients was 58 (range:
34–81 years), and that of the BRTO patients was 59 (range:
26–86 years). However, more women (16) had received
BRTO than TIPS (8; p < 0.05). There were no differences
in the etiologies of the gastric varices, the pre-treatment
Model for End-Stage Liver Disease (MELD) scores, or portal
hypertension complications, namely, hepatic encephalopathy
and ascites (p > 0.05).
TIPS
The TIPS procedure had been performed under moderate
sedation or general anesthesia according to the patient’s
condition, and prophylactic antibiotics were administered
to all patients. The hepatic vein was accessed from a
right internal jugular approach, and wedged hepatic
venography was performed to localize the portal vein. The
portal vein was then accessed using a Colapinto needle
(Cook Inc., Bloomington, IN, USA) passed from the right
or middle hepatic vein. Pressures were measured in the
right atrium and the portal vein to determine a preTIPS portosystemic gradient, and portal venograms were
obtained. The parenchymal tract was then pre-dilated and
then dilated using an 8–10 mm angioplasty balloon, and
a 10-mm covered stent (Viatorr [n = 24], W. L. Gore and
Korean J Radiol 18(2), Mar/Apr 2017
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Associates Inc., Flagstaff, AZ, USA; Flucency [n = 2], Bard
Peripheral Vascular, Tempe, AZ, USA; Viabahn [n = 1], W. L.
Gore and Associates Inc.) was placed. After the TIPS was
created, portal venography was performed with the catheter
positioned in the splenic vein to assess for filling of any
gastric varices; the varices were embolized if persistent
filling was noted. A final mean portosystemic gradient
was measured and optimized to be < 12 mm Hg. Technical
success for each TIPS procedure was defined per the Society
of Interventional Radiology reporting standards as the
creation of a patent TIPS between the hepatic vein and a
branch of the portal vein (16).
BRTO Procedure
The BRTO procedure was performed under moderate
sedation via the transfemoral or transjugular approach
following placement of a 9–10 French sheath based on
the size and anatomy of the gastrorenal shunt; this shunt
was selected and catheterized via the left renal vein, with
occlusion balloon catheters such as a 6 Fr wedge pressure
catheter (Teleflex Medical, Arrow International Inc., Wayne,
PA, USA) or a 6 Fr Berenstein occlusion balloon catheter
(Boston Scientific, Natick, MA, USA) advanced to the

shunt coaxially over the stiff guide wire. Balloon-occluded
retrograde venography was performed to evaluate the
anatomy of the shunt and varices. After embolization of
any collateral veins including the inferior phrenic vein with
a 2.7 Fr microcatheter (Progreat; Terumo Medical, Elkron,
MD, USA) and 3–6 mm microcoils (Nester Coil; Cook Inc.).
With the occlusion balloon inflated, the sclerosant was
administered to fill the varices under fluoroscopic guidance.
Ethanolamine oleate (16–20 cc) mixed with Lipiodol
(Ethiodol; Savage Laboratories, Melville, NY, USA) was used
as the sclerosant for the initial four patients, and 8–16
cc sodium tetradecol sulfate (Sotradecol; AngioDynamics,
Queensbury, NY, USA) mixed with Lipiodol and air (2:1:3
ratio) was used as the sclerosant for the remaining patients.
The occlusion balloon remained inflated post procedure for
4–20 hours (mean inflation time: 13 hours) according to the
timing of the procedure and was removed after stagnation
of the sclerosant was confirmed on follow-up abdominal
radiography. Technical success for the BRTO procedure was
defined as successful placement of the occlusion balloon in
the gastrorenal shunt and administration of the sclerosant
mixture into the varices.

Table 1. Baseline Characteristics for Patients Who Underwent TIPS vs. BRTO for Isolated Gastric Varices
Demographics
Male
Mean age (years)†
Gastric varices etiology‡
Alcohol
Viral hepatitis (B and/or C)
NASH
Cryptogenic
Portal vein/splenic vein thrombosis
Primary biliary cirrhosis
Autoimmune hepatitis
Medication related cirrhosis*
Pre-procedure†
Ascites
Hepatic encephalopathy
Total bilirubin (mg/dL)
INR
Creatinine (mg/dL)
MELD score

TIPS (n = 27)

BRTO (n = 25)

P

19
58 (13)

9
59 (2.5)

< 0.05

14
10
4
2
1
0
0
0
5
1
2.2 (1.4)
1.5 (0.3)
0.8 (0.3)
13 (3.6)

6
9
2
4
1
1
1
1
7
1
3.5 (7.2)
1.4 (0.3)
0.9 (0.3)
14 (4.9)

0.27
0.27
0.19
0.95
0.55
0.21

*Patient with hepatic C status post liver transplant and was thought to have drug related cirrhosis of allograft, †Numbers in parentheses
represent standard deviation, ‡Some patients had multiple etiologies (i.e., hepatitis C + alcohol). BRTO = balloon-occluded retrograde
transvenous obliteration, INR = international normalized ratio, MELD = Model for End-Stage Liver Disease, NASH = nonalcoholic
steatohepatitis, TIPS = transjugular intrahepatic portosystemic shunts
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Endoscopy and Imaging Follow-Up
The patients were followed with endoscopy every 3–6
months following the BRTO procedure. All patients who
presented with re-bleeding underwent endoscopy to
determine the source of the bleeding.
Doppler ultrasonography (US) was performed at 1, 3, 6,
and 12 months following TIPS placement and every 6–12
months thereafter unless there was intervening clinical
deterioration.
Computed tomography (CT) or magnetic resonance (MR)
imaging was performed at 3–6 months following each BRTO
procedure to confirm variceal obliteration.
Analysis
Early re-bleeding was defined as recurrent bleeding within
seven days following the TIPS or BRTO procedure, and late
re-bleeding was defined as recurrent bleeding after seven
days following the procedure. Hepatic encephalopathy was
defined and the degree characterized based on the West
Haven Criteria for quantitative grading of mental state in
hepatic encephalopathy (17).
We used the chi-squared test and Fisher’s exact test to
compare differences in baseline characteristics, the rates
of complications, re-bleeding, new hepatic encephalopathy,
new ascites, repeat intervention, and resolution of gastric
varices on follow-up endoscopies, and a p value of < 0.05
was considered statistically significant. We calculated
survival using the Kaplan-Meier estimator and performed all

statistical analyses with MedCalc Software (Version 16.8,
Ostend, Belgium).

RESULTS
Technical Success
Technical success was achieved in 100% of the patients
who received a TIPS (27 of 27) and 88% of the patients
who underwent BRTO (22 of 25); the BRTO failures were
balloon ruptures (n = 2) and a right common femoral artery
injury (n = 1). As noted before, ten of the 27 TIPS patients
underwent supplemental gastric varices embolization with
multiple coils. The mean portosystemic gradients pre-TIPS
and post-TIPS measured 15 ± 5.4 mm Hg and 6 ± 3.3 mm
Hg, respectively, with a mean decrease of 9 ± 5.7 mm Hg in
the portosystemic gradient following TIPS.
Procedural Complications
There were no statistically significant differences in
procedural complications between the TIPS and BRTO
groups (p = 0.57) (Table 2). Within the TIPS group, one
patient had an episode of oxygen desaturation that required
bag ventilation and administration of naloxone to return
to baseline. Another patient had a 5 mm coil placed for
variceal embolization that migrated to the left lower lobe
pulmonary artery but remained asymptomatic. In the BRTO
group, two patients experienced balloon rupture within six
hours of inflation, and one of these patients underwent

Table 2. Comparing Outcomes of TIPS vs. BRTO for Isolated Gastric Varices
Procedural complications
Yes
Post procedure labs*
Mean # days after procedure
Total bilirubin (mg/dL)
INR
Serum creatinine (mg/dL)
MELD score
Change in MELD score
Clinical outcomes
New hepatic encephalopathy
New ascites
Rebleeding
Rebleeding from GV source
Mean follow-up (days)*

TIPS (n = 27)

BRTO (n = 25)

P

2

3

0.57

64 (262)
2.1 (1.4)
1.5 (0.1)
0.8 (0.3)
13 (3.3)
+1 (0.9)

88 (117)
3.7 (9.5)
1.5 (0.4)
1.0 (0.5)
13 (6.4)
0 (3.6)

0.68
0.46
0.98
0.11
0.97
0.21

6
1
3
2
917 (908)

0
1
3
2
727 (533)

0.01
0.96
0.92
0.94
0.03

*Numbers in parentheses represent standard deviation. BRTO = balloon-occluded retrograde transvenous obliteration, GV = gastric varices,
INR = international normalized ratio, labs = laboratory examinations, MELD = Model for End-Stage Liver Disease, TIPS = transjugular
intrahepatic portosystemic shunts
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TIPS due to presumed gastric variceal bleeding one day
later. Another patient sustained a common femoral artery
injury during the process of acquiring femoral venous
access, and this required an open arteriotomy repair. It was
not possible to leave the occlusion balloon and sheath, and
therefore, the gastrorenal shunt was embolized with coils
to retain the sclerosant in the varix before the balloon was
deflated and the sheath removed; this patient underwent
TIPS due to presumed gastric variceal bleeding two days
later (Fig. 1).
Outcomes
There were no differences in immediate post-procedure
laboratory values (total bilirubin, INR, serum creatinine)
and MELD scores during the follow-up period (TIPS: mean,
64 days vs. BRTO: mean, 88 days; p > 0.05) (Table 2).
There was a significantly higher rate of hepatic
encephalopathy within the TIPS group (6 of 27 patients;
22%) than in the BRTO group (0 of 25 patients; 0%, p =
0.01) (Table 2). Among the six patients who were treated
for hepatic encephalopathy in the TIPS group, five were
documented as having trivial lack of awareness (grade 1),
and one was noted to have mild disorientation to time and
place (grade 2). All patients demonstrated improvement
upon discharge.
There was no statistically significant difference in
development of new ascites following TIPS (4%) or BRTO
(4%, p = 0.96) (Table 2). There was also no statistically
significant difference in re-bleeding rates from gastric
varices between the TIPS (2/27, 7%) and BRTO groups (2/25,
8%; p = 0.94) (Table 2). Figure 2 illustrates re-bleeding
after TIPS or BRTO in 52 patients. Among the TIPS group,
three patients (3/27, 11%) presented with early and late
re-bleeding (gastric varices: n = 2; gastric ulcer: n = 1).
One patient developed hematemesis two days following
TIPS placement from gastric varices, which was successfully
treated with coil embolization. Two additional patients
presented with hematemesis: one case was 18 months
following TIPS, from an oozing gastric ulcer–although
no varices were seen–and was successfully treated with
epinephrine injection, and the other, two years following
TIPS, was re-bleeding from gastric varices that was treated
with TIPS revision due to stenosis (Fig. 3).
Among the BRTO group, three patients (12%) presented
with early and late re-bleeding (gastric varices: n = 2;
esophageal varices: n = 1). One patient who had a balloon
rupture within six hours presented with hematemesis one
kjronline.org
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day following the procedure from presumed gastric variceal
bleeding and was treated with TIPS and coil embolization
of the gastric varices. A second patient with right femoral
artery injury presented with hematemesis from presumed
gastric variceal bleeding two days following the procedure
and was treated with TIPS (Fig. 1). One patient presented
with hematemesis nine months later from esophageal
variceal bleeding, which was subsequently treated with
endoscopic band ligation.
The mean survival for the patients who received TIPS was
30 months, and for those who underwent BRTO, it was 24
months; there was no statistically significant difference
between the two groups (p = 0.16). The median survival for
the patients who received TIPS was 16.6 months, and for
those who underwent BRTO, it was 26.6 months.
Endoscopy and Imaging Follow-Up
Significantly more patients who underwent BRTO received
follow-up endoscopy, and of these, the gastric varices were
resolved in 87% of the patients who underwent BRTO (13 of
15) and in 60% of those who received TIPS (3 of 5) (Table
2). However, these differences did not approach statistical
significance. One TIPS patient demonstrated persistent
gastric varices at three-month follow-up endoscopy;
because of the increased risk of bleeding, the patient
subsequently underwent TIPS revision. Among the BRTO
group, one patient presented with persistent gastric varices,
which decreased in size on nine-month follow-up endoscopy
and remained asymptomatic and thus did not require any
intervention. Another patient presented with recurrent
gastric varices 3.5 years following the BRTO procedure
with no bleeding episodes and thus did not require further
intervention.
Two patients in the TIPS group underwent TIPS revision
due to US Doppler findings suggesting shunt stenosis.
Fifteen patients in the BRTO group underwent follow-up CT
or MR imaging during follow-up that demonstrated complete
obliteration of the gastric varices in all patients.

DISCUSSION
Variceal bleeding remains a serious complication of portal
hypertension. Although treatment of esophageal varices
is well established with endoscopic methods, the longterm success of gastric varices is limited in part due to the
high flows through the varix and also the location of the
varices in the cardia/gastric fundus (18). In addition, due
349
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to their size, sclerosis of the gastric varices often requires
larger volumes of sclerosant and poses a higher risk of
pulmonary system embolization (19). TIPS has been widely

used for decades to manage gastric varices, and BRTO has
emerged as an alternative treatment method, specifically
among patients in the United States for whom TIPS is

A

B

C

D

Fig. 1. 68-year-old woman with nonalcoholic steatohepatitis cirrhosis and recurrent gastric variceal bleeding.

A. Balloon-occluded venogram of gastro-renal shunt shows contrast filling of gastric varices (arrows) along with draining inferior phrenic
collateral vein (open arrow). B. Inferior phrenic vein was embolized with microcoils (open arrow). This was followed by injection of sodium
tetradecyl sulfate (Sotradecol; AngioDynamics) mixed with Lipiodol into gastric varices (arrows). C. It was not possible to leave occlusion balloon
and sheath due to common femoral artery injury while obtaining femoral venous access. Therefore, gastrorenal shunt was embolized with multiple
coils (open arrow) to retain sclerosant (arrows) in gastric varices before balloon was deflated and sheath was removed. D. Patient presented
with hematemesis two days following procedure. TIPS was performed due to presumed gastric variceal bleeding. Venogram after TIPS placement
showed no gastric varix filling from afferent veins and dense Lipiodol uptake (arrows) in gastric varices. Portosystemic gradient decreased from
15 mm Hg to 5 mm Hg. TIPS = transjugular intrahepatic portosystemic shunts
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contraindicated (20).
Limited intra-institutional studies have compared the
outcomes of TIPS and BRTO in managing gastric varices
(9, 10, 11). In a study by Choi et al. (9), patients with
active gastric variceal bleeding due to liver cirrhosis were
treated with either TIPS (n = 13) or BRTO (n = 8), and no
statistically significant differences were noted in either
immediate hemostasis or re-bleeding (9). A larger study
by Ninoi et al. (10) evaluated 104 patients, 27 of whom
were treated with TIPS and 77 of whom were treated with
transcatheter sclerotherapy. The cumulative gastric variceal
bleeding rates at one year were significantly better in the
BRTO group (TIPS: 20% vs. BRTO: 2%). Furthermore, survival
rates at 1, 3, and 5 years following BRTO were better than
those after TIPS. However, the improved survival was only
statistically significant for patients classified as Child-Pugh
class A (as opposed to class B or C) prior to treatment. It
is important to note that the TIPS procedures in that study
used bare metal stents, which are known to have lower
patency than covered stents and which likely accounted
for the higher re-bleeding rates (21). More recently, Sabri
et al. (11) demonstrated equivalent short-term re-bleeding
for isolated gastric varices managed by TIPS with covered

stents (11%) and BRTO (0%, p = 0.25). Similar to the
results reported by Sabri et al. (11), our study demonstrated
no significant difference in gastric varix re-bleeding
between the two groups (p = 0.94).
In the TIPS group, three patients (3/27, 11%) presented
with early and late re-bleeding (gastric varices: n = 2;
gastric ulcer: n = 1). The two patients who had re-bleeding
from their gastric varices were subsequently treated with
coil embolization of the varices and TIPS revision due to
stenosis (Fig. 3).
In the BRTO group, three patients (12%) presented with
early and late re-bleeding (gastric varices: n = 2; esophageal
varix: n = 1). Two patients presented with presumed gastric
variceal bleeding within two days following the procedure,
and they were subsequently treated with TIPS placement.
These early re-bleeding cases were mostly the result of
inadequate sclerosis of the gastric varices. In one patient,
there was balloon rupture within six hours, and in the
other, the balloon was deflated after injection of sclerosant
and coil embolization of gastrorenal shunts due to right
common femoral artery injury (Fig. 1).
Because most fundal gastric varices drain into the left
renal vein via a spontaneous gastrorenal shunt, obliterating

52 patients

TIPS (n = 27)

BRTO (n = 25)

Rebleeding (n = 3)

Rebleeding (n = 3)

Early rebleeding from GV (n = 1)
–treat with coil embolization

Early rebleeding from GV (n = 1)
–treated with TIPS
Balloon rupture (n =1)
Right femoral artery injury (n = 1)

Late rebleeding (n = 1)
Gastric ulcer–treat with epinephrine injection
Rebleeding from GV–treat with TIPS revision

Late rebleeding (n = 1)
Esophageal variceal bleeding
–treat with endoscopic band ligation

Fig. 2. Flowchart summarizing re-bleeding after TIPS or BRTO in 52 patients. BRTO = balloon-occluded retrograde transvenous
obliteration, GV = gastric varices, TIPS = transjugular intrahepatic portosystemic shunts
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the gastric varices excludes the shunt from portosystemic
circulation (1-3), and occluding portosystemic shunts
in BRTO leads to significant changes in portal hepatic
hemodynamics (22). Although transient improvement in

hepatic function has been reported with increased portal
hepatic blood flow, symptoms associated with portal
hypertension can be further exacerbated post treatment
from blood flow diversion.

A

B

C

D

Fig. 3. 47-year-old man with alcoholic liver cirrhosis with acute gastric variceal bleeding.

A. TIPS procedure was performed using 10 x 50 mm Viatorr stent (arrows) and 10 x 68 mm Wallstent (open arrows) extending to hepaticocaval
junction. Portosystemic gradient decreased from 20 mm Hg to 8 mm Hg. Patient presented with recurrent gastric variceal bleeding two years
later. B. TIPS venogram showed tight stenosis (arrows) at TIPS stent near hepaticocaval junction. C. Balloon angioplasty was performed at tight
stenosis (arrows) near hepaticocaval junction. D. TIPS venogram after balloon angioplasty showed interval improvement of stenosis (arrows).
Portosystemic gradient decreased from 15 mm Hg to 5 mm Hg. TIPS = transjugular intrahepatic portosystemic shunts
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One of the most important reported complications
associated with BRTO is aggravated esophageal varices (8,
22); reported rates of worsening esophageal varices vary
up to 63%, with 11–24% subsequent variceal bleeding
(23, 24). The wide range of reported rates is thought to
be related to the variations in patient populations and the
causes and severity of liver disease, as well as the different
follow-up durations (8). In our present study, only one
patient in the BRTO group presented, nine months following
the procedure, with esophageal variceal bleeding, which was
successfully treated with endoscopic band ligation. The rate
of esophageal variceal bleeding in our study was relatively
lower than that reported in the literature, which may in
part have been due to the shorter follow-up duration.
A substantive risk from TIPS is that of severe
encephalopathy, with incidence estimates as high as 20%.
A potential benefit of BRTO is that it avoids this risk
by diverting blood flow (25). In this study, none of the
patients developed encephalopathy in the BRTO group,
whereas six developed new encephalopathy following TIPS
placement.
In our study, the mean pre-TIPS portosystemic gradient
of 15 mm Hg was unusually low. In the study by Chao et al.
(26), the mean hepatic venous pressure gradient was 11.2
mm Hg for gastric varices and 15.5 mm Hg for esophageal
varices. Thus, diminished portal pressure (< 12 mm Hg) is
more likely in patients with gastric varices.
It is difficult to compare the costs between the two
groups including devices, procedure time, follow-up, etc.
BRTO does require post-procedure dwell times for vascular
sheaths in observation or intensive care units in our
hospital; thus, it may be less cost-effective than TIPS
unless the patient is already in intensive care.
This study has a number of limitations. First, it is
retrospective nature and used a relatively small number of
patients. Furthermore, the retrospective nature of the study
limits the ability to evaluate for delayed complications
such as hepatic encephalopathy and development of postprocedure ascites. Significantly more patients in the BRTO
group (15 of 25; 60%) received follow-up endoscopies
than in the TIPS group (5 of 27; 19%), although the mean
follow-up for TIPS patients is significantly longer than that
for BRTO patients. This is likely secondary to the fact that
patients who undergo TIPS are more likely to be followed
for signs of bleeding as opposed to routine endoscopy.
Second, there was selection bias in the choice of TIPS vs.
BRTO with no selection criteria for the choice. Before 2009,
kjronline.org
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TIPS was performed to manage isolated gastric varices, but
since we began BRTO in 2009, the choice of management
technique was based on operator preference.
In conclusion, BRTO is an effective method of treating
isolated gastric varices with similar outcomes and
complication rates as TIPS with a covered stent but lower
rates of hepatic encephalopathy. Multi-center prospective
randomized studies are needed to determine the long-term
outcomes in order to develop tailored treatment strategies
for individual patients who present with isolated gastric
variceal bleeding.
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